November 08, 2018
6 min watch
Save

VIDEO: Sodium zirconium cyclosilicate seen as efficacious, safe for treatment of hyperkalemia

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

SAN DIEGO — In this exclusive video from ASN Kidney Week 2018, Ian Sabir, June Zhao, MD, PhD and Ayman Al-Shurbaji, MD, PhD, discuss a phase III study that compared 5 g and 10 g of Lokelma (sodium zirconium cyclosilicate, AstraZeneca) with placebo for the treatment of hyperkalemia.